Sec Form 13D Filing - Lawless Michael A filing for - 2025-10-29

Insider filing report for Changes in Beneficial Ownership

  • Schedule 13G & 13D forms are used to report a party's ownership of stock which exceeds 5% of a company's total stock issue.
  • Schedule 13G is a shorter version of Schedule 13D with fewer reporting requirements.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>





If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. Checkbox not checked

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).






SCHEDULE 13D



Comment for Type of Reporting Person:
Consists of 3,614,731 Shares of restricted stock granted to employees of the Issuer under the Israeli Appendix of the InspireMD, Inc. 2013 Long-Term Incentive Plan (the "2013 Plan") and Section 5 of the InspireMD, Inc. 2021 Equity Incentive Plan ("the 2021 Plan" and together with the 2013 Plan, the "Plans"). Based upon 41,720,662 Shares issued and outstanding as of August 4, 2025, which amount was provided reported by the Issuer in its Quarterly Report on Form 10-Q for the quarter ended June 30, 2025, as filed with the Securities and Exchange Commission on August 4, 2025. Does not include (i) 465,000 shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of June 25, 2026, June 25, 2027 and June 25, 2028, subject to the Reporting Person's continued service with the Issuer, granted under the InspireMD, Inc. 2024 Inducement Plan (the "Inducement Plan") and (ii) options to purchase 212,000 Shares , which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of June 25, 2026, June 25, 2027 and June 25, 2028, subject to the Reporting Person's continued service with the Issuer, granted under the Inducement Plan.


SCHEDULE 13D

 
Michael A. Lawless
 
Signature:/s/ Michael A. Lawless
Name/Title:Michael A. Lawless
Date:10/29/2025
primary_doc.xml